Articles & Publications , Thierry Van Nieuwenhove

Thierry Van Nieuwenhove comments on the future of Pharma Manufacturing

In this article by Manufacturing Chemist, Thierry Van Nieuwenhove, CEO of Quotient Sciences, discusses the future of pharma manufacturing.

Ahead of the upcoming DCAT, Dr. Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond.

Thierry Van Nieuwenhove, CEO of Quotient Sciences recognizes that sustainability and resilience are critical to the future of pharmaceutical development supply chains.

Continue reading the full article on Manufacturing Chemist.

Latest news from Quotient Sciences

More News

News & Announcements, Articles & Publications, commercial manufacturing, Dr. Helen Baker, Dr. Richard Castledine Dr. Helen Baker and Dr. Richard Castledine contribute to Pharmaceutical Technology's 'Poor API Quality Threatens a Healthy Supply' By: Dr. Helen Baker and Dr. Richard Castledine

News & Announcements, Articles & Publications, Thierry Van Nieuwenhove Thierry Van Nieuwenhove on the Future of CDMO Partnerships By: Thierry Van Nieuwenhove

News & Announcements, Translational Pharmaceutics®, Articles & Publications BioPharm International interviews Helen Baker about how Quotient Sciences is optimizing drug development

More News

Humanity can't afford to wait, so neither can we.

Let's talk